General
publicado em 20/01/2013 às 08h15:00
   Dê o seu voto:

Treatment with drugs orally is 52% more effective in multiple sclerosis

Besides efficacy, the drug contributes to treatment adherence, producing significant improvement in the quality of life of patients

 
font size
A-
A+

Some pieces of information on this page may have been automatically translated. Makernews is not responsible for the irregularities resulting from these translations. When in doubt,      consult the original text.



The Gilenya (fingolimode), Novartis lab, is the first oral treatment for multiple sclerosis (MS) and is bringing satisfactory results for patients with the disease, to facilitate treatment adherence in many ways, unlike options available, such as injectables. Treatment was awarded the Prix Galien Italian 2012, in the category innovator of the year.

When properly follow treatment, be administered orally, MS patient has immediate improvement in quality of life, reduce surge noting that manifests itself in several ways physical and psychological for achieving the central nervous system.

In studies, the drug has also demonstrated effectiveness in reducing upper 52% of outbreaks caused by the disease, compared to one of the most widely used treatments.

Since its global launch, over 49,000 patients have been treated with fingolimode. The drug was approved in Europe in 2011 and is available in the Brazilian market and in several other countries such as United States, Canada, Russia, Australia, Argentina, Chile and Mexico.

Multiple sclerosis is a demyelinating disease of neurological and inflammatory character most common neurodegenerative central nervous system, affecting about 2.5 million people worldwide, according to WHO data. Cause significant and progressive disability in most affected individuals, and the most common cause of acquired neurological disability in young adults.

Source: Isaude.net
   Palavras-chave:   Multiple sclerosis    Gilenya    Fingolimode    Oral treatment    Relapses    Quality of life   
  • Share this pageShare this page
  • Share this pageCorrect
  • ShareShare
  • AlertAlert
Reduced link: 
  • You are recommending this story: Treatment with drugs orally is 52% more effective in multiple sclerosis
  • Fill in the following form to send your recommendation to your friend:

  • You are suggesting a correction for this story: Treatment with drugs orally is 52% more effective in multiple sclerosis


Receba notícias do iSaúde no seu e-mail de acordo com os assuntos de seu interesse.
Seu nome:
Seu email:
Desejo receber um alerta com estes assuntos:
multiple sclerosis    Gilenya    fingolimode    oral treatment    relapses    quality of life   
Comments:
Comment
Leave your comment
Close
(Required fields are marked with an *)

(Your email address will never be published or shared.)

Enter the letters and numbers below and click in the button "send"

  • Twitter iSaúde
advertising
Informe Saúde printed version

Recommend the portal
Close [X]
  • You are recommending this story: http://www.isaude.net
  • Fill in the following form to send your recommendation to your friend:

RSS news from the portal  iSaúde.net
Get the newsletter of the portal  iSaúde.net
Recommend the portal iSaúde.net
News from  iSaúde.net in your blog or website.
Get news on the subject of your interest.
© 2000-2011 www.isaude.net Todos os direitos reservados.